Vitamin D: new roles and therapeutic potential in inflammatory bowel disease.

Hdl Handle:
http://hdl.handle.net/10147/294671
Title:
Vitamin D: new roles and therapeutic potential in inflammatory bowel disease.
Authors:
Raftery, Tara; O'Morain, Colm A; O'Sullivan, Maria
Affiliation:
Department of Clinical Medicine, Trinity College Dublin Centre for Health Sciences, Adelaide & Meath Hospital, Dublin 24, Ireland.
Citation:
Vitamin D: new roles and therapeutic potential in inflammatory bowel disease. 2012, 13 (9):1294-302 Curr. Drug Metab.
Journal:
Current drug metabolism
Issue Date:
Nov-2012
URI:
http://hdl.handle.net/10147/294671
PubMed ID:
22493989
Abstract:
Inflammatory bowel disease (IBD) encompasses 2 independent but related entities: ulcerative colitis (UC) and Crohn's disease. Crohn's disease is characterised by transmural patchy inflammation which can involve any portion of the gastrointestinal tract. UC is characterised by superficial inflammation that begins in the rectum and extends proximally along the colon. In Europe, approximately 2.2 million people have a diagnosis of IBD. The aetiology of IBD is unknown, however, immune, environmental and genetic factors are thought to be involved. Individuals with IBD are at risk of developing osteoporosis. In line with this, there are clear guidelines that recommend vitamin D supplementation for IBD patients to prevent bone disease, especially when undergoing steroid treatment. Despite an established role for vitamin D in IBD, deficiency is common. More novel effects of vitamin D beyond bone are emerging. It is now well established that vitamin D is an important regulator of the immune system which may have implications for the development, severity and management of immune related disorders such as IBD. The efficacy of vitamin D as an immune modulator in IBD remains to be proven. This review aims to evaluate the evidence implicating vitamin D deficiency in IBD pathogenesis, to examine vitamin D's anti-inflammatory mechanisms and to explore its therapeutic potential, optimal serum levels and dietary intakes which may support immune function in this disease.
Item Type:
Article
Language:
en
MeSH:
Animals; Humans; Immunologic Factors; Inflammatory Bowel Diseases; Vitamin D
ISSN:
1875-5453

Full metadata record

DC FieldValue Language
dc.contributor.authorRaftery, Taraen_GB
dc.contributor.authorO'Morain, Colm Aen_GB
dc.contributor.authorO'Sullivan, Mariaen_GB
dc.date.accessioned2013-06-26T13:46:38Z-
dc.date.available2013-06-26T13:46:38Z-
dc.date.issued2012-11-
dc.identifier.citationVitamin D: new roles and therapeutic potential in inflammatory bowel disease. 2012, 13 (9):1294-302 Curr. Drug Metab.en_GB
dc.identifier.issn1875-5453-
dc.identifier.pmid22493989-
dc.identifier.urihttp://hdl.handle.net/10147/294671-
dc.description.abstractInflammatory bowel disease (IBD) encompasses 2 independent but related entities: ulcerative colitis (UC) and Crohn's disease. Crohn's disease is characterised by transmural patchy inflammation which can involve any portion of the gastrointestinal tract. UC is characterised by superficial inflammation that begins in the rectum and extends proximally along the colon. In Europe, approximately 2.2 million people have a diagnosis of IBD. The aetiology of IBD is unknown, however, immune, environmental and genetic factors are thought to be involved. Individuals with IBD are at risk of developing osteoporosis. In line with this, there are clear guidelines that recommend vitamin D supplementation for IBD patients to prevent bone disease, especially when undergoing steroid treatment. Despite an established role for vitamin D in IBD, deficiency is common. More novel effects of vitamin D beyond bone are emerging. It is now well established that vitamin D is an important regulator of the immune system which may have implications for the development, severity and management of immune related disorders such as IBD. The efficacy of vitamin D as an immune modulator in IBD remains to be proven. This review aims to evaluate the evidence implicating vitamin D deficiency in IBD pathogenesis, to examine vitamin D's anti-inflammatory mechanisms and to explore its therapeutic potential, optimal serum levels and dietary intakes which may support immune function in this disease.en_GB
dc.language.isoenen
dc.rightsArchived with thanks to Current drug metabolismen_GB
dc.subject.meshAnimals-
dc.subject.meshHumans-
dc.subject.meshImmunologic Factors-
dc.subject.meshInflammatory Bowel Diseases-
dc.subject.meshVitamin D-
dc.titleVitamin D: new roles and therapeutic potential in inflammatory bowel disease.en_GB
dc.typeArticleen
dc.contributor.departmentDepartment of Clinical Medicine, Trinity College Dublin Centre for Health Sciences, Adelaide & Meath Hospital, Dublin 24, Ireland.en_GB
dc.identifier.journalCurrent drug metabolismen_GB
dc.description.provinceLeinsteren

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.